Česky English Home
ISSN 1802-8861
O projektu
Aktuality
Software SVOD
Epidemiologické analýzy
Průvodce analýzami

INCIDENCE A MORTALITAREGIONÁLNÍ PŘEHLEDYČASOVÉ TRENDYKLINICKÁ STADIAVĚK PACIENTŮSROVNÁNÍ SE ZAHRANIČÍMSROVNÁVACÍ ANALÝZYSOUHRNNÁ PREZENTACE
Publikace, zprávy
WWW odkazy
Kalendář odborných akcí 
Onkologické časopisy 
Služby pro novináře
Varování před dezinformací
Vaše dotazy
Správce portálu


Další související projekty
Oficiální portál Národního onkologického programu České republiky
www.onconet.cz


Národní program screeningu karcinomu prsu v České republice
www.mamo.cz


Národní program screeningu karcinomu děložního hrdla v České republice
www.cervix.cz


Národní program screeningu kolorektálního karcinomu v České republice
www.kolorektum.cz




Přihlásit uživatele





New way to finance the treatment of cancer patients


01.03.2007

On 26/02/2007, Jiri Vorlicek (President of the Czech Oncological Society) and Pavel Horak (President of the General Health Insurance Office) concluded the so-called "Agreement on Understanding", which is regarded as a historical milestone in the Czech oncology. Jiri Vorlicek assumes that other health insurance offices will join this initiative soon.

According to this agreement, expensive treatment will be provided to any cancer patient who needs it. In compliance with the principle of "right treatment to the right patient", the costly treatment will be provided to those patients who can benefit most from it. One of 18 complex cancer centres will take over the treatment of those patients, while the General Health Insurance Office will pay the treatment with the most effective drugs for each specific patient – something that small hospitals could not afford for financial reasons. The system of fixed payment tariffs, which has been implemented so far, has brought a lot of complications to cancer patients, as the health care facilities have been handing those patients over, worrying about the expensive treatment.

The Czech Oncological Society has presented a set of data to the General Health Insurance Office, giving an overview about some types of cancer in the Czech population, as well as estimations for the year 2007 (specifically, breast carcinoma, colorectal carcinoma and non-small cell lung cancer). This analysis has been performed by a team of specialists from the Institute of Biostatistics and Analyses (IBA), which have used the data from the National Cancer Registry, demographic data of the Czech population and the Death Registry; based on known scenarios of cancer treatment, this team has estimated numbers of patients which would be treated with a specific therapy in 2007.

Institute of Biostatistics and Analyses at the Faculty of Medicine and the Faculty of Science of the Masaryk University in BrnoMasaryk Memorial Cancer Institute

O projektu   Aktuality   Software SVOD   Epidemiologické analýzy   Průvodce analýzami      


Citace:   DUŠEK Ladislav, MUŽÍK Jan, KUBÁSEK Miroslav, KOPTÍKOVÁ Jana, ŽALOUDÍK Jan, VYZULA Rostislav. Epidemiologie zhoubných nádorů v České republice [online]. Masarykova univerzita, [2005], [cit. 2017-12-11]. Dostupný z WWW: http://www.svod.cz. Verze 7.0 [2007], ISSN 1802 – 8861.


TOPlist